Black Diamond Therapeutics, Inc. Common Stock
Symbol: BDTX (NASDAQ)
3.75
▼ (-1.19%) -0.045
Company Description:
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Key Stats
- Today's Open: $3.87
- Today's High: $3.863
- Today's Low: $3.675
- Today's Volume: 874.48K
- Yesterday Close: $3.79
- Yesterday High: $3.8399
- Yesterday Low: $3.65
- Yesterday Volume: 1.01M
- Last Min Volume: 0
- Last Min High: $3.758
- Last Min Low: $3.745
- Last Min VWAP: $0
Company Profile
- Name: Black Diamond Therapeutics, Inc. Common Stock
- Website: https://www.blackdiamondtherapeutics.com
- Listed Date: 2020-01-30
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001701541
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $215.78M
- Round Lot: 100
- Outstanding Shares: 56.94M
- Asset Type: CS
RECENT FILINGS FOR BDTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-22 | 4 | View |
| 2025-09-22 | 4 | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 8-K | View |
| 2025-05-12 | 10-Q | View |
| 2025-05-12 | 8-K | View |
| 2025-04-29 | SCHEDULE 13G/A | View |
| 2025-04-18 | ARS | View |
| 2025-04-18 | DEFA14A | View |
| 2025-04-18 | DEF 14A | View |
| 2025-03-21 | 4 | View |
Latest News on BDTX